NASDAQ · EPOW

E – Power Inc.

$0.53 +$0.02 (+3.45%) 1D After hours

Key Metrics

$19.75M
Market cap
P/E · TTM
$46.42M
Revenue · TTM
−$16.64M
Net income
EPS · TTM $-0.65
Dividend yield
Free cash flow −$31.55M
Beta · 1Y -0.29
EBITDA · TTM −$10.35M
Gross margin -12.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    From its Feb 13 high, the share price fell 54%.

    Peak close $1.03 on Feb 13; trough close $0.47 on Jul 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -54%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +29.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Mar 25
    The stock moved +28.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$19.75M
Enterprise value$64.52M
Shares outstanding38.7M
52-wk range$0.46 – $1.86
Avg volume · 20D311.3K
Net cash −$44.76M
Book value / share$-0.47
ExchangeNASDAQ
About E – Power Inc.
IPO dateFeb 9, 2021
Employees266

E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.43
P/FCF
EV/EBITDA
EV/Sales1.39
Graham №

Profitability

Gross -12.6%
Operating -34.5%
Net -35.8%
FCF -68.0%
ROE / ROIC 148.7% · -45.9%

Financial Health

Current ratio0.72
Quick ratio0.48
Debt / equity-5.70
Debt / EBITDA -6.66
Net cash −$44.76M
Working capital−$28.42M

Cash Flow · TTM

Operating CF −$25.16M
Capex −$6.39M
Free cash flow −$31.55M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-0.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings